Litcius/Paper detail

Indirubin-3-monoxime and thymoquinone exhibit synergistic efficacy as therapeutic combination in in-vitro and in-vivo models of Lung cancer

Ayed A. Dera, Prasanna Rajagopalan, Majed Al Fayi, Irfan Ahmed, Harish C. Chandramoorthy

2020Archives of Pharmacal Research26 citationsDOI

Topics & Concepts

ThymoquinoneProtein kinase BApoptosisIn vivoPI3K/AKT/mTOR pathwayIndirubinViability assayChemistryAnnexinCell cyclePharmacologyCancer researchFlow cytometryCell cycle checkpointMedicineBiologyBiochemistryImmunologyArtBiotechnologyIndigoVisual artsAntioxidantBioactive Compounds and Antitumor AgentsCancer therapeutics and mechanismsNigella sativa pharmacological applications
Indirubin-3-monoxime and thymoquinone exhibit synergistic efficacy as therapeutic combination in in-vitro and in-vivo models of Lung cancer | Litcius